Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel plus S-1 in advanced pancreatic cancer
NCT02124317Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, tegafur in pancreatic ductal adenocarcinoma (PDAC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
paclitaxeltegafur
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02124317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124317.